English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/89223
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action

AuthorsCelada, Pau ; Lladó-Pelfort, Laia ; Santana, Noemí ; Kargieman, Lucila ; Troyano-Rodriguez, Eva ; Riga, Maurizio ; Artigas, Francesc
Keywords5-HT receptors
Antipsychotic drugs
NMDA receptors
Prefrontal cortex
Thalamus
Issue Date2013
PublisherCambridge University Press
CitationInternational Journal of Neuropsychopharmacology 16(10): 2145-2163 (2013)
AbstractNon-competitive NMDA receptor antagonists are widely used as pharmacological models of schizophrenia due to their ability to evoke the symptoms of the illness. Likewise, serotonergic hallucinogens, acting on 5-HT2A receptors, induce perceptual and behavioural alterations possibly related to psychotic symptoms. The neurobiological basis of these alterations is not fully elucidated. Data obtained in recent years revealed that the NMDA receptor antagonist phencyclidine (PCP) and the serotonergic hallucinogen 1-(2,5-dimethoxy-4-iodophenyl-2-aminopropane; DOI) produce a series of common actions in rodent prefrontal cortex (PFC) that may underlie psychotomimetic effects. Hence, both agents markedly disrupt PFC function by altering pyramidal neuron discharge (with an overall increase) and reducing the power of low frequency cortical oscillations (LFCO; < 4 Hz). In parallel, PCP increased c-fos expression in excitatory neurons of various cortical areas, the thalamus and other subcortical structures, such as the amygdala. Electrophysiological studies revealed that PCP altered similarly the function of the centromedial and mediodorsal nuclei of the thalamus, reciprocally connected with PFC, suggesting that its psychotomimetic properties are mediated by an alteration of thalamocortical activity (the effect of DOI was not examined in the thalamus). Interestingly, the observed effects were prevented or reversed by the antipsychotic drugs clozapine and haloperidol, supporting that the disruption of PFC activity is intimately related to the psychotomimetic activity of these agents. Overall, the present experimental model can be successfully used to elucidate the neurobiological basis of schizophrenia symptoms and to examine the potential antipsychotic activity of new drugs in development.
Publisher version (URL)http://dx.doi.org/10.1017/S1461145713000643
URIhttp://hdl.handle.net/10261/89223
DOI10.1017/S1461145713000643
ISSN1461-1457
E-ISSN1469-5111
Appears in Collections:(IIBB) Artículos
Files in This Item:
File Description SizeFormat 
Disruption of thalamocortical .pdf879,02 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.